Nuveen, LLC Bausch Health Companies Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Nuveen, LLC holds 227,230 shares of BHC stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
227,230Holding current value
$1.12 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
276Shares Held
233MCall Options Held
5.12MPut Options Held
9.43M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$171 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$136 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$130 Million12.9% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$64.1 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$57.9 Million0.0% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $1.78B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...